Key statistics
On Friday, Hercules Capital Inc (HTGC:NYQ) closed at 16.45, 5.11% above its 52-week low of 15.65, set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 16.56 |
|---|---|
| High | 16.59 |
| Low | 16.32 |
| Bid | 16.51 |
| Offer | 17.00 |
| Previous close | 16.33 |
| Average volume | 2.38m |
|---|---|
| Shares outstanding | 181.72m |
| Free float | 178.57m |
| P/E (TTM) | 9.57 |
| Market cap | 2.99bn USD |
| EPS (TTM) | 1.72 USD |
| Annual div (ADY) | 1.88 USD |
|---|---|
| Annual div yield (ADY) | 11.43% |
| Div ex-date | Nov 12 2025 |
| Div pay-date | Nov 19 2025 |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
- Hercules Capital Prices Institutional Notes Offering of $300.0 Million 5.350% Notes due 2029
- Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call
- Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
- enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
- Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
More ▼
